Suzhou Zelgen Biopharmaceuticals Co., Ltd. (SHA:688266)
China flag China · Delayed Price · Currency is CNY
100.40
+0.98 (0.99%)
Apr 29, 2026, 3:00 PM CST

SHA:688266 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
26,31724,53816,49414,01410,00814,112
Upgrade
Market Cap Growth
-6.82%48.77%17.70%40.02%-29.08%-9.11%
Upgrade
Enterprise Value
25,41923,57815,21312,6589,44313,028
Upgrade
Last Close Price
99.4292.7062.3152.9441.7058.80
Upgrade
Forward PE
47.4935.5135.5135.5135.51-
Upgrade
PS Ratio
32.4730.2830.9536.2633.1174.13
Upgrade
PB Ratio
24.3622.7113.178.5212.7111.26
Upgrade
P/TBV Ratio
25.0723.3713.708.9614.9813.07
Upgrade
P/OCF Ratio
--431.73---
Upgrade
EV/Sales Ratio
31.3629.0928.5432.7631.2468.44
Upgrade
Debt / Equity Ratio
1.051.050.830.540.700.18
Upgrade
Net Debt / Equity Ratio
-0.83-0.83-0.92-0.83-0.63-0.78
Upgrade
Net Debt / EBITDA Ratio
4.474.476.653.821.032.11
Upgrade
Net Debt / FCF Ratio
4.274.2720.094.601.091.86
Upgrade
Asset Turnover
0.270.270.180.170.180.10
Upgrade
Inventory Turnover
0.460.460.260.300.370.19
Upgrade
Quick Ratio
1.541.541.712.081.573.35
Upgrade
Current Ratio
1.711.711.882.221.773.69
Upgrade
Return on Equity (ROE)
-14.16%-14.16%-10.37%-24.27%-47.59%-31.38%
Upgrade
Return on Assets (ROA)
-5.08%-5.08%-4.60%-10.91%-19.70%-17.02%
Upgrade
Return on Capital Employed (ROCE)
-15.80%-15.80%-13.30%-22.70%-57.30%-37.10%
Upgrade
Earnings Yield
-0.62%-0.66%-0.84%-1.99%-4.57%-3.20%
Upgrade
FCF Yield
-0.80%-0.86%-0.35%-2.11%-4.59%-3.72%
Upgrade
Buyback Yield / Dilution
0.85%0.85%-3.71%-6.74%0.19%-2.20%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.